Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results

Go back to Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 44.41 -1.14 (2.5%)
Previous Close $45.55    52 Week High $26.84 
Open $45.71    52 Week Low $9.51 
Day High $45.71    P/E N/A 
Day Low $44.16    EPS $-2.62 
Volume 825,357